Timing of Endoscopy in Cirrhotic Patients With Acute Variceal Bleeding
Key facts
- Who runs it
- General Hospital of Shenyang Military Region
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 368 people, planned
- Started
- 4 Sept 2024
- Expected to end
- Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Endoscopy
- Record updated
- 14 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- patients with AUGIB which is highly suspected to be caused by gastroesophageal variceal rupture
- patients with a diagnosis of liver cirrhosis based on imaging and pathology
- patients and/or their relatives who sign informed consents
- patients' age ≥18 years
Who cannot take part
- patients who have taken anticoagulants or antiplatelet drugs within 2 weeks before admissions, or are diagnosed with severe hematological diseases
- patients with severe cardiovascular or cerebrovascular diseases or renal injury
- patients with human immunodeficiency virus or other acquired or congenital immune deficiency diseases
- patients with mental illness
- patients who have undergone endoscopy at other hospitals before admissions
- patients' hemodynamics are unstable after resuscitation
- pregnancy
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Endoscopy is important for the diagnosis and treatment of acute upper gastrointestinal bleeding (AUGIB), especially acute variceal bleeding (AVB), in patients with liver cirrhosis. However, the optimal timing of endoscopy remains controversial, primarily because the currently available evidence is of poor quality, and the definition of early endoscopy is also very heterogeneous among studies. Herein, a multicenter randomized controlled trial (RCT) is performed to explore the impact of timing of endoscopy on the outcomes of cirrhotic patients with AVB.
The 2 groups in the trial
- Early endoscopy groupTreatment being tested
Intervention of endoscopy is within 12 hours after admission
Treatment: Endoscopy
- Delayed endoscopy groupExisting treatment, for comparison
Intervention of endoscopy is within 12-24 hours after admission
Treatment: Endoscopy
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Timing of endoscopy in cirrhotic patients with acute variceal bleeding: protocol of a multicenter randomized controlled trial.Therapeutic advances in gastroenterology, 2024
- Record updated
- 14 September 2026